Cassava Sciences Q1 EPS $(0.43) Beats $(0.46) Estimate
Portfolio Pulse from Benzinga Newsdesk
Cassava Sciences reported Q1 earnings with losses of $(0.43) per share, surpassing the analyst consensus estimate of $(0.46) and marking a 25.86% improvement over last year's $(0.58) per share loss.
May 10, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cassava Sciences reported a smaller-than-expected Q1 loss per share of $(0.43), outperforming the consensus estimate of $(0.46) and showing significant improvement from the previous year.
Beating earnings estimates typically has a positive impact on a company's stock price in the short term, as it indicates better-than-expected financial health. The improvement over the previous year's losses further strengthens the positive outlook for SAVA.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100